InformedDNA

InformedDNA specializes in genetics benefits management services, aiming to enhance healthcare spending and patient care through expert genomic insights. The company provides a robust platform that connects genetic counselors with patients, focusing on policy development, prior authorization for genetic testing, and payment integrity claims edits. InformedDNA offers utilization analytics and lab network strategies, empowering genetics experts to guide both patients and clinicians in effectively utilizing genetic information and novel gene-based treatments. With the largest independent team of board-certified genetics specialists in the United States, the company combines extensive clinical experience with advanced technology to deliver tailored solutions. InformedDNA is committed to optimizing clinical decisions, managing downstream costs, and improving health outcomes, ensuring that patients receive the highest quality of care through informed decision-making.

Lee Fowinkle

COO, CTO and President

3 past transactions

Coriell Life Sciences

Acquisition in 2025
Coriell Life Sciences, Inc. is a bioinformatics company that specializes in genetic laboratory interpretation and reporting services. Founded in 2013 and based in Philadelphia, Pennsylvania, the company offers a range of solutions aimed at enhancing precision medicine. Among its key products are GeneDose, a medication risk management tool that provides drug-specific guidance, and GeneDose LIVE, which incorporates genetics, demographics, lifestyles, and medical conditions into its advisory framework. Additionally, Coriell provides the GeneVault and GeneExchange platforms, which facilitate the integration of genomic medicine into clinical care while managing genomic data. The company's services cater to various therapeutic areas, including pain management, cardiology, oncology, and infectious diseases, helping healthcare professionals deliver safer and more effective medication regimens tailored to individual patients.

gWell

Acquisition in 2023
gWell is a digital health company that specializes in musculoskeletal (MSK) care. Founded by physicians, the company offers a secure genetic analysis service that identifies an individual's inherited MSK risks. This information is then used to provide personalized, actionable health and wellness tips through a content-rich digital application. By understanding and addressing these risks, users can prevent new injuries or conditions and improve their overall health and wellness. gWell's services are backed by scientific research and are eligible for reimbursement through Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs).

Inherited Health

Acquisition in 2011
Inherited Health is an online health resource combining family health history and professional guidance to identify disease risk. The company makes it easy for consumers to safely and securely gather and store family health information and to get a personalized view of their hereditary disease risks. By providing individuals, their families, and their doctors, with the ability to access and share this critical information, Inherited Health helps everyone in the family take a proactive step in managing their health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.